ArticleBrain structure & function2026
Temporal profiling of hippocampal astrocyte reactivity reveals persistent GFAP cleavage and complement C3 association after status epilepticus.
Article in Brain structure & function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Astrocytes play essential roles in maintaining brain homeostasis, regulating synaptic transmission, supporting neuronal metabolism, and preserving blood-brain barrier integrity. Following prolonged seizures, such as status epilepticus (SE), astrocytes undergo structural and molecular changes that may contribute to epileptogenesis. Although reactive astrogliosis after SE is well documented, the temporal dynamics of astrocytic cytoskeletal remodeling and its relationship to complement activation remain incompletely defined. Using a pilocarpine-induced SE rat model, we examined hippocampal astrocyte responses at multiple time points (4 h, 1 day, 3 days, and 1-, 2-, 3-, or 5-weeks post-SE). Glial fibrillary acidic protein (GFAP) distribution was assessed by immunohistochemistry (IHC), and total GFAP protein levels and cleavage were quantified by western blotting (WB). We further evaluated the cellular association between GFAP-positive astrocytes and complement component C3 by immunofluorescence (IF). IHC revealed progressive astrocytic hypertrophy and increased GFAP immunoreactivity in the CA1 region, peaking at 2-3 weeks post-SE and modestly declining by 5 weeks. In contrast, WB demonstrated sustained elevations in total GFAP protein from 2 to 5 weeks post-SE, accompanied by significant accumulation of GFAP cleavage fragments. Quantitative analysis of GFAP breakdown products revealed progressive proteolytic processing during the latent-to-chronic phases of epileptogenesis. IF showed robust colocalization of C3 within hypertrophic GFAP-positive astrocytes at 2-3 weeks post-SE. When integrated with our prior mapping of microglial activation and complement dynamics, these findings indicate that astrocytic GFAP upregulation and cleavage follow early microglial activation and parallel sustained complement C3 expression. Together, our results demonstrate that SE induces dynamic and persistent astrocytic cytoskeletal remodeling characterized by coordinated GFAP synthesis and proteolysis, along with complement association. These findings highlight GFAP cleavage as a potential marker of astrocytic stress post-SE and support a temporally integrated astroglial-complement response following SE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.